Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Explore a compelling case study demonstrating the intricate relationship between chronic myeloid leukemia, autoimmunity, and post-transplant hematologic complications, highlighting the importance of thorough diagnostics and tailored treatment approaches in managing complex patient scenarios.
Hematology March 18th 2024
Hematology Advisor
Explore the latest insights into the complex pathophysiology of steroid-refractory cGVHD and the significant strides made in treatment options, including the impactful roles of ruxolitinib, belumosudil, and ibrutinib in enhancing patient outcomes.
Hematology March 11th 2024
In light of recent findings, CD24Fc emerges as a potential game-changer in preventing acute GVHD in HSCT patients, with a notable survival rate improvement to 96.2% for severe cases.
Hematology February 12th 2024
Recent studies have highlighted the effectiveness of ruxolitinib in managing steroid-refractory chronic graft-vs-host disease, showcasing a significant improvement in overall response rates and failure-free survival compared to standard therapies.
Hematology February 5th 2024
MDLinx
In a landmark surgical endeavor, neurosurgeons have transferred sciatic nerve components from an amputated foot to the brachial plexus, showcasing the potential of neuroplasticity in restoring hand mobility.
Neurology January 17th 2024
The New England Journal of Medicine
This phase 1–2 study of gene therapy in Crigler–Najjar syndrome patients offers promising insights into a novel treatment approach. Explore the detailed findings to understand how this therapy could revolutionize the management of this rare and severe condition.
Gastroenterology August 22nd 2023